drugset / Trial / NCT00110474

Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis

NCT00110474 ↗

Phase 3 Completed 300 enrolled Rottapharm
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy and safety of glucosamine sulfate versus placebo on the symptoms of knee osteoarthritis after 6 months of treatment, using acetaminophen as a reference symptomatic medication.

Timeline

Start
2000-05
Primary completion
—
Completion
2002-12

Outcome

Met primary endpoint

paper with a final decrease of 3.1 points, versus 1.9 with placebo (difference between glucosamine sulfate and placebo -1.2 [95% confidence interval -2.3, -0.8]) (P = 0.032). PMID 17265490 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg Oral
Subject Glucosamine Small molecule 1500 mg Oral

Indications